Michael SinghAssociateProskauer Rose LLPWebsitewww.proskauer.comOrganization ProfileFull ProfileBlogwww.proskauer.com/pubConnectEmail+44.20.7280.2269 Professional Biography Michael Singh is an associate in the Corporate Department and a member of the Private Funds Group. Mr. Singh graduated from the University of South Wales in 2012. More Legal and Business Bylines From Michael Singh Consumer Duty Implementation: Good Practice and Areas for Improvement - (Posted On Friday, March 01, 2024) Requirements for UK High Net Worth and Self-Certified Investors Changing From 31 January 2024 - (Posted On Wednesday, December 20, 2023) A Step Closer to SFDR Changes Under ESAs’ Final Report - (Posted On Monday, December 18, 2023) Corporate Sustainability Due Diligence Directive – Initial Agreement of Final Text - (Posted On Friday, December 15, 2023) ESMA Update on Funds’ Names Using ESG or Sustainability-Related Terms - (Posted On Thursday, December 14, 2023) FCA Welcomes the Launch of the Transition Plan Taskforce Disclosure Framework – The Relevance for UK Asset Managers - (Posted On Tuesday, December 05, 2023) UK Financial Promotion Rules for Cryptoassets: Longer Implementation Period for Certain Requirements - (Posted On Wednesday, September 13, 2023) Tokenised Funds – Key UK Regulatory Considerations - (Posted On Sunday, August 20, 2023) Buyer Beware – FCA Publishes Financial Promotion Rules for Cryptoassets - (Posted On Saturday, June 10, 2023) UK Rules on Climate-related Disclosures – A Q&A for Asset Managers - (Posted On Monday, March 28, 2022) Pagination Previous page ‹ Previous Page 2 Next page Next › Current Legal Analysis Breaking Down Federal Policies to Address Drug Shortages by: McDermott + Consulting PPPlease Stop Fraud: Two Whistleblowers Awarded $2.5 Million in PPP Fraud Settlement by: Tycko & Zavareei Whistleblower Practice Group On July 1, 2024, Texas May Have the Strongest Consumer Data Privacy Law in the United States by: Elizabeth Rogers 10 Creative Ways for Lawyers to Repurpose Content by: Stefanie M. Marrone FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company by: Dominick DiSabatino , Cortney Inman Upcoming Legal Education Events Jun 26 2024 TSCA Reform — Eight Years Later Jun 18 2024 There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e) Jun 12 2024 Preparing for HHS’s 340B Administrative Dispute Resolution (“ADR”) Reboot – Lessons from the Field Jun 12 2024 Sponsor’s Role in Regulatory Testing — Complying with GLP Standards Print